Air conditioning giant Seeley has won its bid to remove rival Infinair’s trade mark after an IP Australia delegate found the Chinese company had not sold any products under the name.
Vittoria’s Cantarella Bros has lost its long-running trade mark stoush with Italian rival Lavazza after a judge found the coffee manufacturer’s two registered ‘Oro’ marks should be cancelled because the word was previously used by another coffee supplier.
Tech company SARB has won a stay of orders barring it from selling its sensor-based system which the city of Melbourne uses for timing parked vehicles, after a judge found it infringed rival Vehicle Management Systems’ patent.
Payroll services provider PayMe Australia has lost its opposition to fintech Paymend’s bid to trade mark its name, with an IP Australia delegate finding the marks are not substantially identical.
The owner of a car parking patent has appealed a judgment that tossed its patent infringement claims and found it made unjustified litigation threats against car parking technology company Ubipark.
Johnson Winter Slattery has lured to the firm Corrs Chambers Westgarth’s intellectual property litigator Chrystal Dare, who led the historical copyright case over the rights to the Aboriginal flag.
Global cryptocurrency and gambling website Stake.com is fighting to strike out claims in a lawsuit by Sydney-based online investment platform Stake over a planned Australian launch.
German drug maker Boehringer has prevailed in its Federal Court fight against US rival Zoetis over the validity of three patents covering pig vaccines.
Queensland technology company Anteotech has hit back at a lawsuit claiming it misused Ferroglobe’s confidential silicon samples in a patent application after a failed collaboration, saying the global speciality metals producer acquiesced to the use.
Sanofi has lost its bid to limit evidence from experts for Amgen in a patent dispute over a cholesterol-lowering antibody, with a judge dismissing concerns about Amgen having a majority of experts giving concurrent evidence. In an application filed at the beginning of the month, the French pharmaceutical company sought to bar Amgen from relying…